Trials of a new needle-free coronavirus vaccine have begun in Cambridge, the city where it was developed by Professor Jonathan Heeney. The DIOS-CoVax vaccine is administered through a blast of air. It’s the first step towards a 'variant proof' coronavirus vaccine, which aims to protect against the virus that causes COVID-19 and future coronaviruses that threaten pandemics. Volunteers are being vaccinated at the NIHR Cambridge Clinical Research Facility at Cambridge University Hospitals.
There are still places available on this trial. If you would like to take part please contact - [email protected]
There are still places available on this trial. If you would like to take part please contact - [email protected]
- Category
- Academic
- Tags
- Cambridge University, Cambridge research, needle-free
Sign in or sign up to post comments.
Be the first to comment